Hospital

The new CDC-approved app launched January 1, 2023.

Study meets primary and key secondary endpoints, showing clinically meaningful and statistically significant improvements.

With the release of the 2022 AHA/ACC Guidelines for the Management of Heart Failure, patients with HFpEF now have a wider range of treatment options.

The findings provide an alternative delivery strategy for peptide-based drugs and suggest that such techniques and principles could be applied to a broader range of drugs.

In the geographical region of a recent study, data showed melanoma cause high mortality rates in relation to incidence.

Digitizing hub processes can create an efficient and effective tech-driven patient access strategy speeding access to lifesaving therapies.

Patients with depression were significantly less likely to have adequate 12-month adherence to antiplatelets, β-blockers, and statins than those without depression.

Patients with cystic fibrosis are typically administered antibiotics throughout their lives, which can increase the risk for C difficile infections.

There are currently 33 RSV prevention candidates in clinical development using 6 different approaches.

Approximately half of patients with heart failure do not require an implantable monitoring device or do not qualify for thoracic monitoring.

The biopsy test is the first companion diagnostic approved for entrectinib for individuals who do not have an available tissue sample.

The report highlights the growth of personalized medicines with improved efficacy for rare, previously untreatable diseases.

The first episode of the Public Health Matters Video Series features Tom Frieden, MPH, MD, who discusses his background and influence on public health and national policy.

Individuals in metropolitan counties used mental health services more than individuals in rural counties.

The chronic and excessive use of opioids has been associated with a wide range of psychosocial effects on the patient.

Distinguishing between atypical hepatocellular carcinomas and intrahepatic cholangiocarcinoma can be difficult, but researchers identified several reliable MRI features to assist in differentiation.

Black patients aged 18 to 49 years showed a greater association with uncontrolled blood pressure while on an antihypertensive medication.

A prespecified analysis of the DELIVER trial found the SGLT2 inhibitor dapagliflozin to benefit patients in a patient population previously excluded from heart failure outcomes trials.

If approved, glofitamab will treat the most aggressive type of non-Hodgkin lymphoma.

Relative risk calculations show that vaccinated individuals infected with the first Omicron subvariants of COVID-19 could have protection that lasts nearly 3 seasons.

There have been more than 80,000 monkeypox cases reported worldwide.

Mothers, in particular, benefit when they are given longer leaves and policies that offer incentives or wage replacement, analysis indicates.

Lecanemab (Lequembi) approved to treat mild cognitive impairment or mild dementia associated with Alzheimer disease.

Pharmacists need to ensure anticoagulants are held appropriately before and after surgery to prevent complications from for CIED infections.

Ublituximab-xiiy from TG Therapeutics Inc is the first anti-CD20 monoclonal antibody approved for individuals with RMS that is administered as a 1-hour infusion after the starting dose.

The findings show promising clinical activity and a favorable tolerability profile in the treatment of KRASG12C-mutated advanced colorectal cancer.

MenABCWY combines components of 2 vaccines, which help protect against serogroups that cause most cases of the invasive disease.

A better understanding of the pathogenesis of monoclonal gammopathy of clinical significance would help guide clinicians treating the complex condition.

This technology could facilitate equal access to value-based pathways in oncology care and optimize the individual treatment approach.

The novel antibody will receive expedited review, according to the FDA, and already has market authorization in the European Union.